CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-24 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −4,661 | $23.09 | $108K | 984,465 |
| 2026-02-24 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −8,149 | $23.09 | $188K | 976,316 |
| 2026-02-24 | Gao Hanlin Chief Scientific Officer | Grant or award | +26,661 | 1,002,977 | ||
| 2026-02-24 | Hsieh Ming Chief Executive Officer | Grant or award | +19,067 | 816,121 | ||
| 2026-02-24 | Hsieh Ming Chief Executive Officer | Grant or award | +39,802 | 855,923 | ||
| 2026-02-24 | Hsieh Ming Chief Executive Officer | Grant or award | +59,276 | 915,199 | ||
| 2026-02-24 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −10,230 | $23.09 | $236K | 904,969 |
| 2026-02-24 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −21,354 | $23.09 | $493K | 883,615 |
| 2026-02-24 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −31,760 | $23.09 | $733K | 851,855 |
| 2026-02-24 | Hsieh Ming Chief Executive Officer | Grant or award | +69,294 | 921,149 | ||
| 2026-02-23 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −661 | $23.01 | $15K | 327,485 |
| 2026-02-23 | Xie Jian President and COO | Shares withheld for taxes | −655 | $23.01 | $15K | 331,383 |
| 2026-02-23 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −403 | $23.01 | $9K | 951,156 |
| 2026-02-23 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −2,167 | $23.01 | $50K | 797,054 |
| 2026-01-26 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −1,331 | $27.53 | $37K | 951,559 |
| 2026-01-26 | Xie Jian President and COO | Shares withheld for taxes | −4,711 | $27.53 | $130K | 332,038 |
| 2026-01-26 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −3,004 | $27.53 | $83K | 328,146 |
| 2025-12-02 | Xie Jian President and COO | Sale | −1,140 | $28.33 | $32K | 336,749 |
| 2025-12-02 | Gao Hanlin Chief Scientific Officer | Sale | −1,075 | $28.33 | $30K | 952,890 |
| 2025-12-01 | Kim Paul CFO and Treasurer | Shares withheld for taxes | −1,131 | $28.52 | $32K | 331,150 |
Page 4 of 15 · 300 trades